Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States
Clinical trial NCT04958954 · COMPLETED
Trial details
- NCT number
- NCT04958954
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-07
- Primary completion
- 2022-08-31
- Enrollment
- 50000000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.